(Q36600269)

15 August 2017

1 reference

title

Future trends in human brucellosis treatment (English)

1 reference

15 August 2017

0 references

Georgios Pappas

1

1 reference

15 August 2017

Photini Papadimitriou

series ordinal

2

1 reference

15 August 2017

Leonidas Christou

series ordinal

3

1 reference

15 August 2017

Nikolaos Akritidis

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

Expert Opinion on Investigational Drugs

15 August 2017

published in

1 reference

15 August 2017

volume

15

1 reference

15 August 2017

issue

10

1 reference

15 August 2017

page(s)

1141-1149

1 reference

The new global map of human brucellosis.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

Brucellosis and international travel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

Recognition and optimum treatment of brucellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

The effect of levamisole combined with the classical treatment in chronic brucellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

The effect of the doxycycline-rifampicin and levamisole combination on lymphocyte subgroups and functions of phagocytic cells in patients with chronic brucellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1141

10.1517/13543784.15.10.1141

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference